<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36775065</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2666-9919</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Infectious diseases now</Title><ISOAbbreviation>Infect Dis Now</ISOAbbreviation></Journal><ArticleTitle>Symptoms of Long-COVID 1-Year after a COVID-19 outbreak among sailors on a French aircraft carrier.</ArticleTitle><Pagination><StartPage>104673</StartPage><MedlinePgn>104673</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.idnow.2023.104673</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2666-9919(23)00035-0</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">While persistent symptoms have been reported after the coronavirus disease-2019 (COVID-19), long-term data on outpatients with mild COVID-19 are lacking. The objective was to describe symptoms persisting for 12&#xa0;months.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This prospective cohort study on 1767 sailors of an aircraft carrier in which a Covid-19 outbreak occurred during a mission in April 2020 described predefined self-reported symptoms of Long-COVID at 6, 9 and 12&#xa0;months. Logistic-regression analyses were used to identify correlates for Long-COVID at months 6, 9 and 12.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 641 participants, 619 (35%) completed at least one follow-up questionnaire (413 COVID-positive and 206 COVID-negative). Symptoms of Long-COVID were reported by 53.7%, 55.2% and 54.3% of COVID-positive participants vs 31.2%, 23.3% and 40.0% in COVID-negative patients, at 6 (p&#xa0;&lt;.002), 9 (p&#xa0;&lt;.002) and 12&#xa0;months (p&#xa0;=.13), respectively. The most frequent symptoms reported were concentration and memory difficulties, asthenia and sleep disorders.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this study more than half of COVID-positive outpatients reported persistent symptoms up to 12&#xa0;months post-quarantine. These findings suggests that all patients, including those with mild disease, can be affected by Long-COVID. A lack of difference at 12&#xa0;months with COVID-negative patienys prompts caution. The symptoms of Long-COVID are so non-specific that they may be viewed as the consequence of multiple intercurrent factors.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Perisse</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>9th Military Medical Center, Toulon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Cacqueray</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>9th Military Medical Center, Toulon, France; H&#xf4;pital d'Instruction des Arm&#xe9;es Laveran, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delarbre</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Internal Medicine, H&#xf4;pital d'Instruction des Arm&#xe9;es Sainte-Anne, Toulon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marsaa</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>9th Military Medical Center, Toulon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergmann</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Naval Action Force, Toulon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Da Silva</LastName><ForeName>V</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>16th Military Medical Center, Brest, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bronstein</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Respiratory Disease Unit, H&#xf4;pital d'Instruction des Arm&#xe9;es Sainte-Anne, Toulon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paleiron</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Respiratory Disease Unit, H&#xf4;pital d'Instruction des Arm&#xe9;es Sainte-Anne, Toulon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menoud</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Charles de Gaulle Nuclear Aircraft Carrier, Toulon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cobola</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Charles de Gaulle Nuclear Aircraft Carrier, Toulon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verret</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Education, Research and Innovation, French Defense Health Service, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayet</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>French Military Center for Epidemiology and Public Health (CESPA), Marseille, France; UMR 1252 SESSTIM, INSERM-IRD-Universit&#xe9; Aix-Marseille, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bylicki</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Respiratory Disease Unit, H&#xf4;pital d'Instruction des Arm&#xe9;es Sainte-Anne, Toulon, France. Electronic address: olivier.bylicki@intradef.gouv.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Infect Dis Now</MedlineTA><NlmUniqueID>101775152</NlmUniqueID><ISSNLinking>2666-9919</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008889" MajorTopicYN="Y">Military Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000401" MajorTopicYN="N">Aircraft</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aircraft-carrier</Keyword><Keyword MajorTopicYN="N">Long term symptoms</Keyword><Keyword MajorTopicYN="N">SARS-CoV2</Keyword><Keyword MajorTopicYN="N">Symptoms of Long-COVID</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>12</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36775065</ArticleId><ArticleId IdType="pmc">PMC9918313</ArticleId><ArticleId IdType="doi">10.1016/j.idnow.2023.104673</ArticleId><ArticleId IdType="pii">S2666-9919(23)00035-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard n.d. https://covid19.who.int (accessed March 27, 2022).</Citation></Reference><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382:727&#x2013;733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghayda R.A., Lee J., Lee J.Y., Kim D.K., Lee K.H., Hong S.H., et al. Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2020;17:E5026. doi: 10.3390/ijerph17145026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17145026</ArticleId><ArticleId IdType="pmc">PMC7400047</ArticleId><ArticleId IdType="pubmed">32668763</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239&#x2013;1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerman B.A., Gerlovin H., Madenci A.L., Kurgansky K.E., Ferolito B.R., Figueroa Mu&#xf1;iz M.J., et al. Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in U.S. Veterans N Engl J Med. 2022;386:105&#x2013;115. doi: 10.1056/NEJMoa2115463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2115463</ArticleId><ArticleId IdType="pmc">PMC8693691</ArticleId><ArticleId IdType="pubmed">34942066</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg E.S., Dorabawila V., Easton D., Bauer U.E., Kumar J., Hoen R., et al. Covid-19 Vaccine Effectiveness in New York State. N Engl J Med. 2022;386:116&#x2013;127. doi: 10.1056/NEJMoa2116063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2116063</ArticleId><ArticleId IdType="pmc">PMC8693697</ArticleId><ArticleId IdType="pubmed">34942067</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F., Perego E. How and why patients made Long Covid. Soc Sci Med. 1982;2021(268) doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>The Lancet null Facing up to long COVID. Lancet Lond Engl. 2020;396:1861. doi: 10.1016/S0140-6736(20)32662-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32662-3</ArticleId><ArticleId IdType="pmc">PMC7834723</ArticleId><ArticleId IdType="pubmed">33308453</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (NICE); 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings G., Monaghan A., Xue F., Mockler D., Romero-Ortu&#xf1;o R. A Systematic Review of Persistent Symptoms and Residual Abnormal Functioning following Acute COVID-19: Ongoing Symptomatic Phase vs. Post-COVID-19 Syndrome. J Clin Med. 2021;10:5913. doi: 10.3390/jcm10245913.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245913</ArticleId><ArticleId IdType="pmc">PMC8708187</ArticleId><ArticleId IdType="pubmed">34945213</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J., Wiernik E., Robineau O., Carrat F., Touvier M., Severi G., et al. Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic. JAMA Intern Med. 2022;182:19&#x2013;25. doi: 10.1001/jamainternmed.2021.6454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.6454</ArticleId><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38 doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>de Laval F., Chaudet H., Gorg&#xe9; O., Marchi J., Lacrosse C., Dia A., et al. a retrospective cohort study. Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull. April 2020;2022:27. doi: 10.2807/1560-7917.ES.2022.27.21.2100612.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.21.2100612</ArticleId><ArticleId IdType="pmc">PMC9137271</ArticleId><ArticleId IdType="pubmed">35620999</ArticleId></ArticleIdList></Reference><Reference><Citation>Bylicki O., Paleiron N., Janvier F. An Outbreak of Covid-19 on an Aircraft Carrier. N Engl J Med. 2021;384:976. doi: 10.1056/NEJMc2034424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2034424</ArticleId><ArticleId IdType="pubmed">33567182</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus Disease 2019 (COVID-19) 2021 Case Definition | CDC 2021. https://ndc.services.cdc.gov/case-definitions/coronavirus-disease-2019-2021/ (accessed March 27, 2022).</Citation></Reference><Reference><Citation>Meynard J.-B., de Laval F., Texier G., Gorg&#xe9; O., Degui H., Pommier de Santi V. Management of the COVID-19 epidemic in the carrier battle group (January-April 2020) by the Armed Forces Epidemiology and Public Health Center. Bull Acad Natl Med. 2022;(206):997&#x2013;1010. doi: 10.1016/j.banm.2022.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.banm.2022.07.008</ArticleId><ArticleId IdType="pmc">PMC9301959</ArticleId><ArticleId IdType="pubmed">35879932</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardo M.D.M., Foppiani A., Peretti G.M., Mangiavini L., Battezzati A., Bertoli S., et al. Long-Term Coronavirus Disease 2019 Complications in Inpatients and Outpatients: A One-Year Follow-up Cohort Study. Open Forum. Infect Dis. 2021;8:ofab384. doi: 10.1093/ofid/ofab384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab384</ArticleId><ArticleId IdType="pmc">PMC8344801</ArticleId><ArticleId IdType="pubmed">34386546</ArticleId></ArticleIdList></Reference><Reference><Citation>Desgranges F., Tadini E., Munting A., Regina J., Filippidis P., Viala B., et al. Post-COVID-19 Syndrome in Outpatients: a Cohort Study. J Gen Intern Med. 2022 doi: 10.1007/s11606-021-07242-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-07242-1</ArticleId><ArticleId IdType="pmc">PMC8939498</ArticleId><ArticleId IdType="pubmed">35319081</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty S.E., Guo Y., Heath K., Dasmari&#xf1;as M.C., Jubilo K.G., Samranvedhya J., et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021;373 doi: 10.1136/bmj.n1098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhea E.M., Logsdon A.F., Hansen K.M., Williams L.M., Reed M.J., Baumann K.K., et al. The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice. Nat Neurosci. 2021;24:368&#x2013;378. doi: 10.1038/s41593-020-00771-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00771-8</ArticleId><ArticleId IdType="pmc">PMC8793077</ArticleId><ArticleId IdType="pubmed">33328624</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Campion J.Y., Dudouet P., Kaphan E., Bregeon F., Tissot-Dupont H., et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2021;48:2823&#x2013;2833. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M., Abo Omirah M., Hussein A., Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021;75:e13746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374 doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Nemati H., et al. Risk Factors Associated with Long COVID Syndrome: A Retrospective Study. Iran J Med Sci. 2021;46:428&#x2013;436. doi: 10.30476/ijms.2021.92080.2326.</Citation><ArticleIdList><ArticleId IdType="doi">10.30476/ijms.2021.92080.2326</ArticleId><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., McMullan C., Chandan J.S., et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18:e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen M.S., Kristiansen M.F., Hanusson K.D., Danielsen M.E., Steig &#xc1;.B., Gaini S., et al. Long COVID in the Faroe Islands: A Longitudinal Study Among Nonhospitalized Patients. Clin Infect Dis Off Publ Infect Dis Soc Am. 2021;73:e4058&#x2013;e4063. doi: 10.1093/cid/ciaa1792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>